QL Block in Laparoscopic Myomectomy

Launched by JOSEPH FINDLEY MD · Jul 28, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a technique called a quadratus lumborum (QL) block, which is an injection given in the lower back to help reduce pain after surgery. Specifically, the trial is focused on patients who are having a myomectomy, a procedure to remove uterine fibroids while keeping the uterus intact. Researchers want to find out if the QL block can lower the level of pain after surgery compared to standard pain management alone. Participants will be randomly placed into two groups: one group will receive the QL block along with regular care, and the other group will only receive the standard care.

To be eligible for this trial, participants should be women aged between 18 and 65 who have fibroids that need to be surgically removed. They must be willing to follow the study's procedures and provide informed consent. However, individuals with certain conditions, such as anxiety, depression, or chronic pain issues, and those who are not able to understand the study materials may not qualify. If you decide to participate, you can expect to receive either the QL block or standard care during your treatment, and the outcomes will help researchers understand how effective this new approach is for managing pain after myomectomy surgery.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Presence of uterine fibroids requiring surgical excision with preservation of the uterus
• • Stated willingness to comply with all study procedures and availability for the duration of the study
• • Provision of signed and dated informed consent form
• Exclusion Criteria:
• • Pre-existing diagnoses of anxiety or depression
• • Pre-existing coagulopathies
• • Pre-existing neuropathic or chronic pelvic pain
• • Chronic opioid use
• • Illiteracy due to inability to read and understand plain questionnaire
• • Non-English speaking
• • BMI \>38